Weidemann, F., Krämer, J., Duning, T., Lenders, M., Canaan-Kühl, S., Krebs, A., . . . Brand, E. (2014). Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch. American Society of Nephrology.
Citação norma ChicagoWeidemann, Frank, et al. Patients With Fabry Disease After Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch. American Society of Nephrology, 2014.
ציטוט MLAWeidemann, Frank, et al. Patients With Fabry Disease After Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch. American Society of Nephrology, 2014.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.